《Clinical And Experimental Hypertension》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱臨床和實(shí)驗(yàn)性高血壓,本刊主要出版、報(bào)道醫(yī)學(xué)-PERIPHERAL VASCULAR DISEASE領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.5,最新CiteScore 指數(shù)為3.9。
本刊近期中國學(xué)者發(fā)表的論文主要有:
Inhibition of endoplasmic reticulum stress restores the balance of renal RAS components and lowers blood pressure in the spontaneously hypertensive rats
Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions.
Features special issues covering proceedings of symposia on hypertension research!
Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including:
antihypertensive agents
circulatory control
drug development and application
etiology
mechanisms of action
neurogenic mechanisms
pathophysiology
pharmacological and nonpharmacological treatment
and much more!
中科院SCI分區(qū)
Clinical And Experimental Hypertension雜志中科院分區(qū)信息